In 2016 interferon free treatment of hepatitis C has been established as standard of therapy, wherever access is possible. Efficacy is impressive in HCV genotype 1 and 4, but there is still room for improvement in other genotypes and specific patient populations. For hepatitis B therapy new research activities are visible, which may influence clinical practice in the coming years. Progress in understanding the pathophysiology of NASH is remarkable. But progress has also been made in other areas of interest.
Hepatology – A clinical textbook is an up-to-date source of information for physicians, residents and advanced medical students seeking a broader understanding of all aspect of liver disease.
Dr. Stefan Mauss
Grafenberger Allee 128a
Telephone +49 (0) 211 239 55 20
Fax +49 (0) 211 239 55 210
Schaafkopp.de | Mediendesign
Hepatology 2016 is supported by an unrestricted educational grant from AbbVie.
© 2016 Medizin Fokus Verlag